Document is current
Any future updates will be listed below
-
Authors
Medianfar, Cecilia Egede https://orcid.org/0009-0006-5537-0385
Kursawe Larsen, Christoffer https://orcid.org/0000-0003-2989-9198
Saunte, Sara Karoline https://orcid.org/0009-0007-4977-2094
Saunte, Ditte Marie Louise https://orcid.org/0000-0001-7953-1047
Jemec, Gregor Borut Ernst https://orcid.org/0000-0002-0712-2540
Andersen, Rune Kjærsgaard https://orcid.org/0000-0003-0159-670X
-
Funding
Funding for this research was provided by:
Zealand Region
- License Information
-
More Information
Article History
Received: 8 July 2024
Revised: 18 August 2024
Accepted: 14 September 2024
First Online: 28 September 2024
Declarations
:
: GBEJ has received honoraria from AbbVie, Chemocentryx, Coloplast, Incyte, Inflarx, Novartis, Pierre Fabre, and UCB for participation on advisory boards, and grants from Abbvie, Astra-Zeneca, Inflarx, Janssen-Cilag, Leo Pharma, Novartis, Regeneron, and Sanofi, for participation as an investigator, and received speaker honoraria from AbbVie, Boehringer-Ingelheim, Galderma and MSD. He has also received unrestricted departmental grants from Abbvie, Leo Pharma, and Novartis. DMLS reports personal fees from AbbVie, Janssen, Jamjoon Pharma, and Sanofi grants, and personal fees from Abbvie, Leo Pharma, and Novartis outside the submitted work. RKA reports that his attendance at the Nordic Congress of Dermato-Venerology hosted in Copenhagen in 2022 was funded by Eli Lilly. CEM, CKL and SKS have nothing to declare.
: Under Danish laws and regulations questionnaire studies without the use of human biological material, and with written consent from the participants may use and report chart data/medical information (letters, numbers and other clear data) without the prior approval from an ethics committee ( & ).
